Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Hayes

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Journal of Hepatology|June 24, 2014
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleedingAdrian J Stanley, Sheila Dickson, Peter C Hayes, et al.
Addiction (Abingdon, England)|March 4, 2017
Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in ScotlandJack Stone, Natasha K Martin, Matthew Hickman, et al.
BMC Gastroenterology|April 1, 2010
Development of an invasively monitored porcine model of acetaminophen-induced acute liver failurePhilip N Newsome, Neil C Henderson, Leonard J Nelson, et al.
Gut|October 17, 2020
Guidelines on the management of ascites in cirrhosisGuruprasad P Aithal, Naaventhan Palaniyappan, Louise China, et al.
Hepatology (Baltimore, Md.)|July 18, 2009
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedDhiraj Tripathi, James W Ferguson, Narendra Kochar, et al.
Journal of Hepatology|May 13, 2022
Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557]Alan Yeung, Norah E Palmateer, John F Dillon, et al.
Journal of Hepatology|October 11, 2021
Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugsAlan Yeung, Norah E Palmateer, John F Dillon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort studyHamish Innes, Scott A McDonald, Victoria Hamill, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohortHuan Wang, Hamish Innes, Sharon J Hutchinson, et al.
Journal of Hepatology|June 6, 2022
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysisCàndid Villanueva, Ferran Torres, Shiv Kumar Sarin, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|June 24, 2014
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleedingAdrian J Stanley, Sheila Dickson, Peter C Hayes, et al.
Addiction (Abingdon, England)|March 4, 2017
Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in ScotlandJack Stone, Natasha K Martin, Matthew Hickman, et al.
BMC Gastroenterology|April 1, 2010
Development of an invasively monitored porcine model of acetaminophen-induced acute liver failurePhilip N Newsome, Neil C Henderson, Leonard J Nelson, et al.
Gut|October 17, 2020
Guidelines on the management of ascites in cirrhosisGuruprasad P Aithal, Naaventhan Palaniyappan, Louise China, et al.
Hepatology (Baltimore, Md.)|July 18, 2009
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedDhiraj Tripathi, James W Ferguson, Narendra Kochar, et al.
Journal of Hepatology|May 13, 2022
Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557]Alan Yeung, Norah E Palmateer, John F Dillon, et al.
Journal of Hepatology|October 11, 2021
Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugsAlan Yeung, Norah E Palmateer, John F Dillon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort studyHamish Innes, Scott A McDonald, Victoria Hamill, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohortHuan Wang, Hamish Innes, Sharon J Hutchinson, et al.
Journal of Hepatology|June 6, 2022
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysisCàndid Villanueva, Ferran Torres, Shiv Kumar Sarin, et al.
Pageof 17